Area of research
Neurology · General Health Professions
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Transcranial Magnetic Stimulation Studies, and Health, Medicine and Society.
Intronic <i>FGF14</i> GAA repeat expansions impact progression and survival in multiple system atrophy
Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
The Impact of Type 2 Diabetes in Parkinson's Disease
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study
The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers
Genome‐Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The <scp>COVID</scp>‐19 Experience
Impact of<i>GBA1</i>variants on long-term clinical progression and mortality in incident Parkinson’s disease
Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial
Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders
Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome
Modulation of Beta Bursts in the Subthalamic Nucleus Predicts Motor Performance
Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
Differences in <scp>MDS</scp>‐<scp>UPDRS</scp> Scores Based on Hoehn and Yahr Stage and Disease Duration
Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force
A genomic approach to therapeutic target validation identifies a glucose-lowering <i>GLP1R</i> variant protective for coronary heart disease